http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2522582-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a1fff28208e2d2d5f3bdc4b73abe3d4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
| filingDate | 2009-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98a4eaffd80c1bc177ec557576e8f3b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64cccb4f8b1ef486289e18c1738d8115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59788b6937204e65d49b1965b076504e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8805b5ba571c91042396ecb4c2ded7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5185fecff05d078ff66c4b96cb3a5323 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca5982b360a48c3813b70d553e7e52c |
| publicationDate | 2014-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2522582-C2 |
| titleOfInvention | New antimicrobial agents |
| abstract | FIELD: medicine, pharmaceutics.SUBSTANCE: given invention refers to a compound of formulaits stereoisomers, including R and S isomers, wherein: 'A' represents N; Y and Y' represent O; '---' is absent; Rand Rare identical or different, and independently represent hydrogen or Calkyl; Rrepresents hydrogen; Rrepresents heteroaryl which can be optionally substituted in any acceptable position by one or more substitutes R; Z represents -(CH)-heteroaryl which can be optionally substituted in any acceptable position by one or more substitutes R; T, U, V and W are identical or different, and independently represent hydrogen or halogen; Ris independently specified in hydrogen, halogen, Calkyl, Chaloalkyl, -C(=Y)OR, -(CH)YR, each of which can be optionally substituted in any acceptable position by halogen; Rrepresents hydrogen or Calkyl; m represents 1; m? represents 0; n represents 1; wherein: the above heteroaryl is specified in 1,2,3-triazolyl, pyridinyl, 1-oxypyridinyl (pyridinyl-N-oxide), pyrazinyl, isoxazolyl, imidazo[1,2-?]pyrimidinyl, imidazo[1,2-?]pyrazinyl. The compounds of the given invention are applicable to prevent, relieve and/or treat bacterial infections in an individual. The bacterial infection is caused by the drug-resistant species Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-resistant species like Mycobacterium tuberculosis, as well as linezolid-resistant species Staphylococcus and Enterococcus.EFFECT: phenyloxazolidinone compounds as antimicrobial agents.12 cl, 8 tbl, 3 ex |
| priorityDate | 2008-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.